WCLC 2019 – The use of video-assisted lung surgery reduces the complications of lobectomy


  • Elena Riboldi — Agenzia Zoe
  • Univadis
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • Lobectomy by video-assisted thoracoscopic surgery (VATS) is associated with less pain, significantly lower in-hospital complications and a shorter length of stay compared to lobectomy by thoracotomy.
  • The use of keyhole surgery does not affect early oncologic outcomes (lymph node dissection, upstaging of mediastinal nodes, complete resection).

 

Why this matters

  • There is limited information from high quality randomised controlled trials on clinical efficacy, safety, and oncologic outcomes of VATS for lung cancer.

 

Study design

  • The VIOLET trial enrolled 503 patients with known/suspected lung cancer within cT1-3 cN0-1 M0 (TNM8).
  • Patients were allocated (1:1 ratio; stratification by operator) to VATS (1-4 ports) or open surgery; patients were blinded to allocation.
  • Lymph node dissection and pain management were standardised.
  • The primary outcome was physical function at 5 weeks.
  • Pain was assessed on day 1-2 through Visual Analogue Scale; the pain score was adjusted for amounts of analgesics.

 

Key results

  • Rates of benign resection, in-hospital mortality, and conversion to open surgery were 1.2%, 1.4%, and 6.4%, respectively.
  • Compared to patients in the open surgery arm, patients in the VATS arm had a lower pain score on day 2 (difference -0.49;  P=0.044).
  • Patients in the VATS arm experienced less in-hospital adverse events (32.8% vs 44.3%; RR 0.74; P
  • Intra-operative bleeding occurred in 6.2% of patients undergoing VATS and in 3.9% of patients undergoing open surgery.
  • The median length of stay was 4 days with VATS and 5 days with open surgery (HR for discharge 1.34; P=0.006).
  • Rates of complete resection were similar (97.4% with open surgery, 97.8% with VATS).
  • The number of lymph node stations harvested was identical (median 5; IQR 4-6).
  • Nodal upstaging from cN0/1 to pN2 disease was observed in 6.2% patients in the VATS arm and 4.8% patients in the open surgery arm (P=0.503).

Funding

  • UK National Institute for Health Research.

Expert commentary

“I think this is a well-designed and well-executed multi-institutional prospective trial. They clearly show that VATS is associated with fewer complications and decreased pain, while maintaining equivalent oncologic outcomes. I think that going forward we cannot accept thoracotomy as a standard of care for early-stage lung cancer.” Jessica S. Donington, MD, University of Chicago Medicine, USA.